Taguchi S - Search Results

1

Six-year outcomes of robot-assisted radical prostatectomy versus volumetric modulated arc therapy for localized prostate cancer: A propensity score-matched analysis.

Noda M, Taguchi S, Shiraishi K, Fujimura T, Naito A, Kawai T, Kamei J, Akiyama Y, Yamada Y, Sato Y, Yamada D, Nakagawa T, Yamashita H, Nakagawa K, Abe O, Fukuhara H, Kume H. Noda M, et al. Among authors: taguchi s. Strahlenther Onkol. 2024 Aug;200(8):676-683. doi: 10.1007/s00066-023-02192-5. Epub 2024 Jan 5. Strahlenther Onkol. 2024. PMID: 38180494 Free PMC article.

2

Zoledronic acid administration in aggressive castration- resistant prostate cancer.

Taguchi S, Fujimura T, Kume H, Homma Y. Taguchi S, et al. Asian Pac J Cancer Prev. 2012;13(12):6539-40. doi: 10.7314/apjcp.2012.13.12.6539. Asian Pac J Cancer Prev. 2012. PMID: 23464489 Free article. No abstract available.

3

Prognostic factors for metastatic urothelial carcinoma undergoing cisplatin-based salvage chemotherapy.

Taguchi S, Nakagawa T, Hattori M, Niimi A, Nagata M, Kawai T, Fukuhara H, Nishimatsu H, Ishikawa A, Kume H, Homma Y. Taguchi S, et al. Jpn J Clin Oncol. 2013 Sep;43(9):923-8. doi: 10.1093/jjco/hyt096. Epub 2013 Jul 25. Jpn J Clin Oncol. 2013. PMID: 23888082

4

Ultra-early versus early salvage androgen deprivation therapy for post-prostatectomy biochemical recurrence in pT2-4N0M0 prostate cancer.

Taguchi S, Fukuhara H, Azuma T, Suzuki M, Fujimura T, Nakagawa T, Ishikawa A, Kume H, Igawa Y, Homma Y. Taguchi S, et al. BMC Urol. 2014 Oct 16;14:81. doi: 10.1186/1471-2490-14-81. BMC Urol. 2014. PMID: 25323845 Free PMC article.

5

Combination of docetaxel, ifosfamide and cisplatin (DIP) as a potential salvage chemotherapy for metastatic urothelial carcinoma.

Kakutani S, Fukuhara H, Taguchi S, Nagata M, Niimi A, Hattori M, Miyazaki H, Fujimura T, Nakagawa T, Kume H, Igawa Y, Homma Y. Kakutani S, et al. Among authors: taguchi s. Jpn J Clin Oncol. 2015 Mar;45(3):281-5. doi: 10.1093/jjco/hyu201. Epub 2014 Nov 25. Jpn J Clin Oncol. 2015. PMID: 25425701

6

Risk factors for clinical metastasis in men undergoing radical prostatectomy and immediate adjuvant androgen deprivation therapy.

Taguchi S, Fukuhara H, Kakutani S, Takeshima Y, Miyazaki H, Suzuki M, Fujimura T, Nakagawa T, Igawa Y, Kume H, Homma Y. Taguchi S, et al. Asian Pac J Cancer Prev. 2014;15(24):10729-33. doi: 10.7314/apjcp.2014.15.24.10729. Asian Pac J Cancer Prev. 2014. PMID: 25605166 Free article.

7

Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of survival in patients with metastatic urothelial carcinoma: A multi-institutional study.

Taguchi S, Nakagawa T, Matsumoto A, Nagase Y, Kawai T, Tanaka Y, Yoshida K, Yamamoto S, Enomoto Y, Nose Y, Sato T, Ishikawa A, Uemura Y, Fujimura T, Fukuhara H, Kume H, Homma Y. Taguchi S, et al. Int J Urol. 2015 Jul;22(7):638-43. doi: 10.1111/iju.12766. Epub 2015 Apr 22. Int J Urol. 2015. PMID: 25903328

8

Validation of major prognostic models for metastatic urothelial carcinoma using a multi-institutional cohort of the real world.

Taguchi S, Nakagawa T, Uemura Y, Matsumoto A, Nagase Y, Kawai T, Tanaka Y, Yoshida K, Yamamoto S, Enomoto Y, Nose Y, Sato T, Ishikawa A, Fujimura T, Fukuhara H, Kume H, Homma Y. Taguchi S, et al. World J Urol. 2016 Feb;34(2):163-71. doi: 10.1007/s00345-015-1631-3. Epub 2015 Jul 2. World J Urol. 2016. PMID: 26135306

9

Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma.

Taguchi S, Akamatsu N, Nakagawa T, Gonoi W, Kanatani A, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Homma Y. Taguchi S, et al. Clin Genitourin Cancer. 2016 Jun;14(3):237-43. doi: 10.1016/j.clgc.2015.07.015. Epub 2015 Aug 6. Clin Genitourin Cancer. 2016. PMID: 26337653

10

Lower ureteral lesion is an independent predictor of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.

Otsuka M, Taguchi S, Nakagawa T, Kawai T, Morikawa T, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Homma Y. Otsuka M, et al. Among authors: taguchi s. Urol Oncol. 2016 Feb;34(2):59.e9-13. doi: 10.1016/j.urolonc.2015.08.015. Epub 2015 Sep 26. Urol Oncol. 2016. PMID: 26411547

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

868 results

Search Page

Filters